Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Do Early Events Excluding Patients with Acute Promyelocytic Leukemia (APL) From Trial Enrollment Modify Treatment Result Evaluation? Real-Life Management of 100 Patients Referred to the University Hospital Saint-Louis Between 2000 and 2010.

Jean-Baptiste Micol, Emmanuel Raffoux, MD, Nicolas Boissel, MD, PhD, Etienne Lengliné, MD, Emmanuel Canet, Thierry Leblanc, Marie-Thérèse Daniel, Adrienne de Labarthe, Odile Maarek, Bruno Cassinat, Christine Chomienne, MD, PhD, Lionel Adès, André Baruchel, Laurent Degos, Elie Azoulay, MD, PhD, Hervé Dombret

Blood (2010) 116 (21): 1083.

https://doi.org/10.1182/blood.V116.21.1083.1083

Published: 2010

Journal Articles

High Body Mass Index (BMI) as a Predictor of Differentiation Syndrome (DS) In Acute Promyelocytic Leukemia (APL).

Ramzi Jeddi, Béchir Achour, Agnès Guerci-Bresler, Héla Ghédira, Hervé Dombret, Françoise Huguet, Patrice Chevallier, Norbert Vey, Stephane de Botton, Dominique Bordessoule, Beatrice U. Muller, Virginie Eclache, Claude Gardin, Balkis Meddeb, Lionel Adès, Pierre Fenaux, MD, PhD

Blood (2010) 116 (21): 1078.

https://doi.org/10.1182/blood.V116.21.1078.1078

Published: 2010

Journal Articles

Response to Azacytidine (AZA) in MDS or AML with Del 5q : Current Results of the French ATU Program

Blood (2008) 112 (11): 2682.

https://doi.org/10.1182/blood.V112.11.2682.2682

Published: 2008

Journal Articles

Use of the Propensity Score Matching Method to Reduce Recruitment Bias in Observational Studies: Application to the Estimation of Survival Benefit of Non-Myeloablative Allogeneic Transplantation In Patients with Multiple Myeloma Relapsing after a First Autologous Transplantation.

Lionel Karlin, Bertrand Arnulf, Sylvie Chevret, Marie Robin, Regis Peffault de Latour, Marion Malphettes, Nabil Kabbara, Bouchra Asli, Lionel Adès, Vanderson Rocha, Jean-Paul Fermand, Gerard Socié

Blood (2008) 112 (11): 1133.

https://doi.org/10.1182/blood.V112.11.1133.1133

Published: 2008

Journal Articles

Treatment of Myelodysplastic Syndromes with del 5q before the Lenalidomide Era: The GFM Experience.

Charikleia Kelaidi, MD, Sophie Park, MD, Sabine Brechignac, MD, Lionel Mannone, MD, Norbert Vey, MD, Herve Dombret, MD, Lina Aljassem, MD, Aspasia Stamatoullas, MD, Lionel Adès, MD, Stéphane Giraudier, MD, Stéphane de Botton, MD, Béatrice Mahé, MD, Pascale Lepelley, MD, Françoise Picard, MD, Geneviève Leroux, MD, Marie-Thérèse Daniel, MD, Didier Bouscary, MD, François Dreyfus, MD, Pierre Fenaux, MD

Blood (2006) 108 (11): 2678.

https://doi.org/10.1182/blood.V108.11.2678.2678

Published: 2006

Journal Articles

Risk Factors for Late Infections after Allogeneic Hematopoietic Stem Cell Transplantation from a Matched Related Donor.

Marie Robin, Raphaël Porcher, Renato De Castro Araujo, Régis Peffault de Latour, Agnès Devergie, Vanderson Rocha, Jérome Larghero, Hélène Espérou, Lionel Adès, Eliane Gluckman, Patricia Ribaud, Jean-Yves Mary, Gérard Socié

Blood (2006) 108 (11): 2848.

https://doi.org/10.1182/blood.V108.11.2848.2848

Published: 2006

Journal Articles

Long-term outcome of hepatitis C infection after bone marrow transplantation

Régis Peffault de Latour, Vincent Lévy, Tarik Asselah, Patrick Marcellin, Catherine Scieux, Lionel Adès, Richard Traineau, Agnès Devergie, Patricia Ribaud, Hélène Espérou, Eliane Gluckman, Dominique Valla, Gérard Socié

Blood (2004) 103 (5): 1618–1624.

https://doi.org/10.1182/blood-2003-06-2145

Published: 2004

NARROW

Do Early Events Excluding Patients with Acute Promyelocytic Leukemia (APL) From Trial Enrollment Modify Treatment Result Evaluation? Real-Life Management of 100 Patients Referred to the University Hospital Saint-Louis Between 2000 and 2010.

High Body Mass Index (BMI) as a Predictor of Differentiation Syndrome (DS) In Acute Promyelocytic Leukemia (APL).

Response to Azacytidine (AZA) in MDS or AML with Del 5q : Current Results of the French ATU Program

Use of the Propensity Score Matching Method to Reduce Recruitment Bias in Observational Studies: Application to the Estimation of Survival Benefit of Non-Myeloablative Allogeneic Transplantation In Patients with Multiple Myeloma Relapsing after a First Autologous Transplantation.

Treatment of Myelodysplastic Syndromes with del 5q before the Lenalidomide Era: The GFM Experience.

Risk Factors for Late Infections after Allogeneic Hematopoietic Stem Cell Transplantation from a Matched Related Donor.

Long-term outcome of hepatitis C infection after bone marrow transplantation

Email alerts

ASH Publications

American Society of Hematology

Do Early Events Excluding Patients with Acute Promyelocytic Leukemia (APL) From Trial Enrollment Modify Treatment Result Evaluation? Real-Life Management of 100 Patients Referred to the University Hospital Saint-Louis Between 2000 and 2010.

High Body Mass Index (BMI) as a Predictor of Differentiation Syndrome (DS) In Acute Promyelocytic Leukemia (APL).

Response to Azacytidine (AZA) in MDS or AML with Del 5q : Current Results of the French ATU Program

Use of the Propensity Score Matching Method to Reduce Recruitment Bias in Observational Studies: Application to the Estimation of Survival Benefit of Non-Myeloablative Allogeneic Transplantation In Patients with Multiple Myeloma Relapsing after a First Autologous Transplantation.

Treatment of Myelodysplastic Syndromes with del 5q before the Lenalidomide Era: The GFM Experience.

Risk Factors for Late Infections after Allogeneic Hematopoietic Stem Cell Transplantation from a Matched Related Donor.

Long-term outcome of hepatitis C infection after bone marrow transplantation

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only